| # | Drug | Count |
|---|---|---|
| 0 | RANITIDINE | 1172 |
| 1 | NIRAPARIB | 620 |
| 2 | ESTROGENS, CONJUGATED | 612 |
| 3 | CONJUGATED ESTROGENS | 611 |
| 4 | MEDROXYPROGESTERONE ACETATE | 504 |
| 5 | BEVACIZUMAB | 324 |
| 6 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 307 |
| 7 | CARBOPLATIN | 297 |
| 8 | LETROZOLE | 293 |
| 9 | RANITIDINE HYDROCHLORIDE | 287 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RELACORILANT | 3 | 0.0303 |
| 1 | NIRAPARIB | 620 | 0.0280 |
| 2 | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | 10 | 0.0270 |
| 3 | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | 10 | 0.0269 |
| 4 | PLATINUM | 12 | 0.0226 |
| 5 | MIRVETUXIMAB SORAVTANSINE | 33 | 0.0182 |
| 6 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 2 | 0.0133 |
| 7 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 307 | 0.0131 |
| 8 | CAMPHOR (SYNTHETIC), LEVOMENTHOL, AND CAPSICUM | 1 | 0.0122 |
| 9 | CAMPHOR (SYNTHETIC) AND MENTHOL, UNSPECIFIED FORM | 1 | 0.0119 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 218 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 133 |
| 2 | Aromatase Inhibitor [EPC] | 116 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 107 |
| 4 | Platinum-based Drug [EPC] | 103 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 89 |
| 6 | Corticosteroid [EPC] | 84 |
| 7 | Microtubule Inhibitor [EPC] | 78 |
| 8 | Interferon beta [EPC] | 67 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 64 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 31 | 0.0014 |
| 3 | Estrogen [EPC] | 218 | 0.0012 |
| 4 | Provitamin D2 Compound [EPC] | 31 | 0.0010 |
| 5 | Aromatase Inhibitor [EPC] | 116 | 0.0010 |
| 6 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 7 | Reducing and Complexing Thiol [EPC] | 2 | 0.0008 |
| 8 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 9 | Estrogen Receptor Antagonist [EPC] | 25 | 0.0006 |